find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.
43
Clinical Trials
Multiple Myeloma
N/A
Enrolling
nct/study# N/A / TECLISTAMAB
Real-World Safety Analysis of Teclistamab, the B-cell maturation antigen and CD3 bi-specific T-cell engager in patients with relapsed and refractory multiple myeloma: Support for Outpatient Step-Up Dosing
Learn More
Multiple Myeloma
Phase I/II
Enrolling
nct/study# NCT06630806 / TED18162
A first-in-human, open label, phase I/II study to evaluate the safety, anti-tumor activity, pharmacokinetics, and pharmacodynamics of SAR446523 monotherapy, an anti-GPRC5D ADCC-enhanced monoclonal antibody in dose escalation and dose optimization, and to evaluate the efficacy of SAR446523 in dose expansion, in participants with relapsed and refractory multiple myeloma.
Learn More
Multiple Myeloma
N/A
Enrolling
Multiple Myeloma
N/A
Enrolling
nct/study# N/A / TRIPLET-VS-QUADRUPLET-OUTCOMES
Outcomes at First Relapse for Patients with Multiple Myeloma who receive Triplet versus Quadruplet Induction Therapy
Learn More
Multiple Myeloma
N/A
Enrolling
nct/study# N/A / MM-TRANSPLANT-OUTCOMES
Transplant outcomes in patients with multiple myeloma
Learn More
Multiple Myeloma
N/A
Enrolling
nct/study# NCT00000000 / VTE-NDMM
Incidence of Venous Thromboembolism in Patients with Newly Diagnosed Multiple Myeloma
Learn Morewe are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.